lilly retatrutide A Study of (LY3437943) in Participants With Obesity and Cardiovascular Disease (TRIUMPH-3) ESC 2024: Retatrutide improves lipid

How long can I take GLP-1 therapy

Use Cases Adjunctive Glycemic Control in Type 2 Diabetes: GLP-1 receptor agonists are incorporated with diet and physical activity to reduce blood glucose levels

You don't need endless cardio

Retatrutide achieved 24% loss in 48 weeks while semaglutide achieved 17% in 68 weeks and tirzepatide achieved 22% in 72 weeks

[00:28:40] Emily Field: Because if we just want this whole episode talking about why muscle matters, why training matters, and why preserving strength matters, then we also have to acknowledge this

GLP-1 medications are considered a highly effective weight loss drug, providing sustainable results for those struggling with obesity